Vivo Bio Tech Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 118.746 million compared to INR 141.07 million a year ago. Net income was INR 22.276 million compared to INR 13.119 million a year ago. Basic earnings per share from continuing operations was INR 1.73 compared to INR 1.02 a year ago. Diluted earnings per share from continuing operations was INR 1.7 compared to INR 1.02 a year ago. For the nine months, total revenue was INR 356.939 million compared to INR 410.262 million a year ago. Net income was INR 53.85 million compared to INR 48.475 million a year ago. Basic earnings per share from continuing operations was INR 4.18 compared to INR 3.76 a year ago. Diluted earnings per share from continuing operations was INR 4.12 compared to INR 3.76 a year ago.